Don't want ads? Subscribe or login now.

Semler Scientific, Bard To Pay $37M To End FCA Claims

By Sydney Price · September 26, 2025, 9:13 PM EDT

The Department of Justice announced on Friday that two companies have agreed to pay nearly $37 million to resolve claims that they knowingly recommended healthcare providers submit erroneous Medicare claims for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Kane et al v. Semler Scientific, Inc. et al

Case Number

3:16-cv-01516

Court

Florida Middle

Nature of Suit

Qui Tam (31 U.S.C. § 3729(a))

Date Filed

December 08, 2016

Recent Articles By Sydney

September 24, 2025
UnitedHealth Fights Investor Suit Over DOJ's Merger Probe
September 23, 2025
Axsome Settles Investors' Drug Approval Suit For $7.8M
September 10, 2025
DexCom Beats Most Of Investors' Diabetes Device Sales Suit
August 25, 2025
Healthcare Co. Investors Sue Over Contractor's Alleged Fraud
August 22, 2025
Rite Aid Execs Dodge Investor Suit Over Opioid Litigation
August 19, 2025
3D Systems Brass Sued Over Revenue Projections
July 31, 2025
Biotech Co. Beats Investor Suit Over Antifungal Drug Recall
July 30, 2025
ImmunityBio Investors Nab Initial OK On Derivative Suit Deal
July 29, 2025
Ocugen Beats Investor Suit Over Financial Controls
July 23, 2025
Medical Device Co. Faces Investor Suit Over Sales Decline